Using perforated patch recordings in combination with intracellular Ca 2÷ ([Ca2+]~) fluorescence measurements, we have identified a delayed Ca2+-dependent CI-current in a mammalian sympathetic ganglion cell. This CI current is induced by the synergistic action of Ca 2+ and diacylglycerol (DAG) and is blocked by inhibitors of protein kinase C. As a result, the current can be induced by acetylcholine through the conjoint activation of nicotinic receptors (to produce a rise in [Ca2+]~) and muscarinic receptors (to generate DAG). This demonstrates an unusual form of synergism between the two effects of a single transmitter mediated via separate receptors operating within a time scale that could be of physiological significance.
Introduction
Through stimulation of the appropriate G protein-linked receptors, many neurotransmitters are capable of activating phospholipase C (PLC). This enzyme catalyses the formation of diacylglycerols (DAGs), which in turn activate protein kinase C (PKC) (Nishizuka, 1986) . Activation of PKC by exogenous DAGs or analogs can phosphorylate and modulate many different ion channels (reviewed by Shearman et al., 1989; Knox and Kaczmarek, 1992 ; for some other examples, see Chen and Huang, 1992; Yang and Tsien, 1993; Swartz, 1993; Zhang et al., 1994; Zhu and Ikeda, 1994) . Hence, it might be supposed that the PLC-DAG-PKC pathway would constitute a very frequently used mechanism for the activation or inhibition of ion channels by neurotransmitters. However, the list of well-documented examples of such an operational pathway in the vertebrate nervous system is surprisingly limited (for examples see Burgess et al., 1989; Rane et al., 1989; Boland et al., 1991 ; Chen and Huang, 1991 ; Aniksztejn et al., 1992; Plata-Salaman and ffrench-Mullen, 1994) .
To take an instance of relevance to the present experiments: in sympathetic neurons, it has long been known that synaptic activation and stimulation of muscarinic acetylcholine receptors (mAChRs) accelerates phosphoinositide breakdown (Hokin et al., 1960; Larrabee et al., 1963; Larrabee and Leicht, 1965; Bone et al., 1984; Horwitz et al., 1984; Patterson and Voile, 1984; Briggs et al., 1985; Pfaffinger et al., 1988) . This leads to substantial DAG production (Wakade et al., 1991) . Further, one prominent ionic response of these neurons to mAChR stimulation, the closure of KM channels, can readily be induced by activating PKC with phorbol esters or DAGs (Brown and Adams, 1987; Brown et al., 1989; Selyanko et al., 1990) . Hence, one might readily suppose that KM channel closure following mAChR stimulation results from receptormediated formation of DAG and consequent PKC activation. Notwithstanding, tests with PKC inhibitors have, so far, totally failed to substantiate this hypothesis (Bosma and Hille, 1990; Selyanko et al., 1990 ; reviewed by Bosma et al., 1990) .
We have now identified a different, and rather novel, response of these neurons to PKC activation following mAChR stimulation, namely, the enhancement or induction of a membrane CI-current. This arose from some observations on membrane current responses to the rise in intracellular Ca 2÷ ([Ca2÷]~) associated with the opening of voltage-gated Ca 2÷ channels (Trouslard et al., 1993) . During these experiments, we noted that, some seconds after the initial Ca 2÷ transient, there sometimes followed a delayed inward membrane current. In the present paper, we show that this delayed current is a CI-current and that it is greatly enhanced by the simultaneous activation of PKC, either by exogenous DAG or by activating PLClinked receptors (such as M1 muscarinic receptors or bradykinin receptors). We go on to show that it results from a synergistic interaction between Ca 2÷ and DAG: in consequence, it can be induced by ACh (the natural transmitter onto these cells) because this simultaneously stimulates nicotinic receptors, to open Ca 2÷ permeable nicotinic channels, and activates muscarinic receptors, to generate DAG. Since even brief applications of ACh suffice to induce the current, this is of potential functional significance.
Results

A Rise in Internal Ca 2+ Activates a Delayed, Slow Inward Current
As previously reported (Trouslard et al., 1993) , brief depolarization of voltage-clamped dissociated rat superior cervical ganglion cells from their resting potential of around -60 mV to 0 mV induces a sharp rise in [Ca2+]~, as a result of Ca 2+ entry through voltage-gated Ca 2÷ channels ( Figure  1A , lower trace). This Ca 2+ transient declined with a time constant of around -4 s at 32°C (see also Trouslard et al., 1993) . As in sensory ganglia (Benham et al., 1991) , recovery of [Ca2÷]~ probably resulted from extrusion by the membrane Ca-ATPase, since recovery was greatly slowed by extracellular alkalinization or intracellular vanadate (data not shown). [Ca2+]~ (lower traces) in a Cs*-filled, dissociated rat superior cervical sympathetic neuron. The cell was clamped at -60 mV and depolarized to 0 mV for 1 s to open voltage-gated Ca 2÷ channels. In normal (Ca 2+-containing) solution (left), this induced a rise in [Ca2+]~ followed some 10 s later by a slow inward current. Current responses to hyperpolarizing steps (-10 mV for 110 ms) show that this inward current is associated with an increased membrane conductance. Ca2+-free external solution (right) abolished both the rise in [Ca2÷]~ and the delayed inward current. (B) Current-voltage curves for the delayed inward current obtained using 53 and 129 mM CI in the recording patch pipette ([CI ]i). Currents were obtained using 250 ms voltage ramps from -60 to +20 mV applied during the slow inward current. Curves show net currents after subtraction of control currents in the presence of tetrodotoxin and pressureejected Ca 2+ free solution, to eliminate Na ÷ and Ca 2÷ currents, respectively.
Simultaneous recording of membrane current with perforated patch electrodes filled with CsCI (to suppress K ÷ currents; see Experimental Procedures) revealed that the Ca 2÷ transient was frequently followed by a slow inward current accompanied by a rise in conductance ( Figure 1A , upper trace). This current peaked some 8-25 s after the initiation of the Ca 2÷ transient, i.e., when [Ca2+]i had returned to basal levels. Notwithstanding its delayed appearance, it seemed to be dependent upon the preceding rise in Ca 2+ since it was not observed in a Ca2+-free solution ( Figure 1A , right) or when the Ca 2÷ channels were blocked with 100 I~M Cd 2÷. On the other hand, application of a Ca2÷-free solution from a localized pressure pipette after the voltage step (which prevented the rise in [Ca2+]~ evoked by a subsequent voltage step) did not affect the amplitude of the current. Further experiments (see, e.g., Figure 3 below) indicated that the Ca 2t threshold required to initiate the slow inward current (as recorded from the whole-cell Indo-1 signal; see Experimental Procedures) was normally between 400 nM and 1 p,M. We also noted that the current became larger and faster on raising the bath temperature from 22°C to 32°C.
The Slow Inward Current Is a CI-Current
The ionic basis of the slow inward current was determined by reversal potential measurements, using voltage ramps ( Figure 1B ). With the standard pipette solution containing 53 mM CI-(Ec~ = -22,4 mV; see Experimental Procedures), the mean reversal potential for the current was -21.9 __+ 2.4 mV (n = 5). When patch pipettes were filled with 129 mM Cr (Ec~ = +1.5 mV), the mean reversal potential was -0.5 _+ 3.5 mV (n = 5). The observed shift of 21.4 mV was comparable with that for the reversal potential of the 7-aminobutyric acid (GABA)-mediated CI-current measured in the same cells (see Adams and Brown, 1975) .
In contrast, the current amplitude was not substantially changed following total substitution of external Na + with glucosamine, Tris, Cs +, or sucrose, or by replacing internal Cs + with K ÷. These observations suggest that the slow inward current at -60 mV was due to the outward movement of CI . In accordance with this, the current was reversibly reduced by 65.5 _+ 6.9% (n = 8) bythe CI-channel blocker niflumic acid (200 I~M; Figure 2 ; see Currie et al., 1995) . This effect was mimicked by 1 mM 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS) or 30-100 p.M 5-nitro-2-(3-phenylpropyl-amino)-benzoic acid (NPPB) (Wangemann et al., 1986; Currie et al., 1995) . (Niflumic acid and NPPB also reduced the rise in Ca 2+ and slowed its extrusion rate, possibly reflecting an interference with Ca 2÷ homeostatic mechanisms or Indo-1 emission spectra, but this was insufficient to explain the reduced current amplitude.)
In spite of the similar reversal potentials, this slow CIcurrent differed from the GABA-activated current in two respects. First, bicuculline (10 t~M) or picrotoxin (10 iiM) blocked the inward current produced by 100 I~M GABA, but did not affect the slow CI-current. Second, and unlike the GABA-activated current in these cells, the slow CI current showed strong inward rectification at potentials negative to -60 mV, as suggested in Figure lB .
Enhancement of the Slow Cl-Current by Muscarinic Receptor Activation
The slow CI-current was consistently enhanced or (when previously absent) induced by the mAChR agonist oxotremorine M (Oxo M) when the latter was added to the bathing fluid at concentrations from 30-100 nM or when focally applied by a pressure pipette containing 1-10 ~M Oxo M, 5-30 s before delivering the voltage step ( Figure  3 ). This was not due to an agonist-induced rise in mediated acceleration of the Ca-ATPase; Smallwood et al., 1988; Hofmann et al., 1994 ; see also below). Instead, Oxo M appeared to increase the sensitivity of the slow CIcurrent to [Ca2+]~ and to reduce the Ca 2÷ threshold required to trigger the current, as indicated in Figure 3C . These effects of Oxo M were qualitatively replicated by another mAChR agonist, muscarine (0.3-10 pM, by bath application; see Figure 4 below) and also by bradykinin (5-10 nM bath application) but not by noradrenaline (10 ~M). Rat superior cervical sympathetic neurons express mRNA for four different mAChRs: M1, M2, M3, and M4 (Buckley, 1990; Brown et al., 1995) . We therefore attempted to identify pharmacologically the subtype responsible for mAChR-induced CI-current enhancement. As illustrated in Figure 4A , enhancement by muscarine was reversibly suppressed by low concentrations (30 or 100 nM) of the M1 mAChR antagonist, pirenzepine (Hammer et al., 1980) . We estimated the dissociation constant for pirenzepine by measuring the increment in CI-current produced by increasing concentrations of muscarine in the absence and presence of 30 or 100 nM pirenzepine. Pirenzepine caused a rightward shift of the dose-response curve, from the magnitude of which a pA2 value (-log Ks; see legend to Figure 4 ) of 8.21 _+ 0.11 (n --7)was calculated ( Figure 4B ). This suggests either M1 or M4 receptors (see Bernheim et al., 1992; Caulfield, 1993) . To differentiate these two, we tested another antagonist, himbacine, which has a high affinity for M4 receptors (Lazareno et al., 1990) . The estimated pA2 for himbacine was 7.08 _+ 0.14 (n = 5; Figure 4B ). This is considerably less than the pA2 for M4 receptors (8-8.8) but accords with that for M1 receptors (7.0-7.2; see Caulfield, 1993) . Hence, we conclude that CI-current enhancement by mAChR agonists results from stimulation of M1 muscarinic receptors.
The Slow Cl-Current Is Regulated by PKC Activation of either muscarinic M1 or bradykinin receptors can stimulate PLC, to yield two primary messenger molecules, inositol 1,4,5-trisphosphate (IPa) and DAG (see, e.g., Rana and Hokin, 1990) . We wondered whether either of these might be responsible for the enhancement of the slow CI current produced by muscarinic agonists or bradykinin. A role for IP3 seemed unlikely because the principal effect of this messenger is to release Ca 2÷ from internal Ca =+ stores (Berridge and Irvine, 1989) , but, as noted above, neither agonist increased [Ca2+]~. Hence, we turned our attention to DAG, one effect of which is to activate PKC (Nishizuka 1986) .
As illustrated in Figure 5A , exogenous application of a DAG, 1,2-dioctanoyl-sn-glycerol (DOG) (5 ~M), also greatly enhanced the slow inward current, with either no effect on or a reduction of the priming Ca 2÷ transient. This effect was replicated using t-oleoyl-2-acetyl-sn-glycerol (OAG) (10 I~M) or by phorbol 12,13-dibutyrate (PDBu) (10 nM-1 ~M; Figure 5B ), either by bath application or by ejection from a pressure pipette 5-30 s before the Ca v loading voltage step. In the presence of PDBu, the current also became greatly prolonged, lasting from 5-10 min. The inactive phorbot ester 4(~-phorbo112,13-didecanoate (4(~- Antagonists were applied for 4 min before the agonists. The antagonist dissociation equilibrium constant KB was calculated from the rightward shift of the agonist dose-response curve (the agonist dose ratio [DR]) according to the expression K8 = B / (DR -1), where B is the antagonist concentration. In the experiments illustrated here, calculated values for KB were these: pirenzepine, 6.28 riM; himbacine, 83.6 nM. Mean values in the text were calculated as the logarithmic transformation pA2 = -log KB, assuming simple competitive inhibition. PDD) (20 ~M) had no effect, suggesting that the effect of PDBu was likely to have resulted from PKC activation. (This was confirmed using PKC inhibitors; see below). Enhancement of the slow CI current was specific to PKC to the extent that it was not replicated by stimulating PKA with 2 mM dibutyryl cAMP (n = 3) or 1 rtM forskolin (n = 4).
To test whether the effect of mAChR stimulation might also be due to PKC activation, we used two approaches: application of PKC inhibitors and down-regulation of PKC. Since we were using perforated patch recording (see Ex- perimental Procedures), it was impracticable to test intracellular PKC inhibitor peptides, so instead we employed two membrane-permeable inhibitors: staurosporine, a broad-spectrum kinase inhibitor (Tamaoki et al., 1986) , and calphostin C, a more selective PKC inhibitor (Bruns et al., 1991) . Staurosporine (1 ~tM) completely and irreversibly blocked the induction of the CI-current within 4 min, but this was accompanied by an increase in resting [Ca2+]~. Calphostin C (100 nM) also produced an increase in resting [Ca2+]~, but this was small (51.5 _+ 18.5 nM; n = 11), and an -2-fold slowing of the Ca 2÷ sequestration rate. Catphostin C prevented the induction or enhancement of the CI-current by both PDBu and Oxo M ( Figure 6 ) and completely eliminated the slow CI current in all cells tested, even following initial Ca 2÷ transients in excess of 2 ixM. To down-regulate PKC, we used a protocol previously employed for sensory neurons, namely, preincubation in 1 ixM PDBu for 18 hr (Burgess et al., 1991) . This reduced, but did not eliminate, the response to subsequent application of PDBu, in that 8 out of 17 cells tested still showed an enhanced current amplitude following pressure ejection of 1 ~tM PDBu. More complete inhibition of the subsequent response to PDBu was achieved by raising external [K ÷] by 45 mM during the 18 hr incubation period, to facilitate the translocation of PKC (Nishizuka, 1986) . This procedure also eliminated the enhancement of the CV current by Oxo M in all eight cells tested ( Figure 6 ). . The mean enhancement of the slow inward current by PDBu was 211 __. 37 pA (n = 12); that by Oxo-M was 100 -4-15 pA (n = 10). Both were significantly greater than that observed after down-regulation or application of calphostin C (p < 0.001; maximum mean response, 13 pA). Responses to ACh were assessed by the presence or absence of the delayed inward current following the fast nicotinic current (see Figure 7) . ACh was applied by iontophoresis (400 nA for 200-600 ms) from a pipette containing 1 M ACh solution. The mean peak amplitude of the nicotinic current and charge transfer (measured from the area under the current) were similar in control and calphostin C-treated cells: for controls (n = 11) current amplitudes were 2.53 -0.23 nA and the charge transfer was 3.19 .4-0.23 nC; for calphostin C (n = 16), the current am plitude was 2.33 + 0.19 nA and the charge transfer was 3.54 -+ 0.33 nC. The mean slow inward current produced byACh (170 -+ 28 pA; n = 11) was significantly greater than that (0 pA) observed in the presence of calphostin C (p < 0.001). To down-regulate PKC, cells were preincubated at 37°C for 18 hr in 1 mM PDBu (Burgess et al., 1989) in the presence of 45 mM K ÷ to raise [Ca2+]~ and so promote PKC translocation and degradation (Nishizuka, 1986) . A corollary to this is that the current might also be induced by the natural transmitter onto these cells, ACh, since this can stimulate both types of receptor. This was clearly the case ( Figure 7B ): the initial large nicotinic (cation) current and accompanying [Ca2+]~ transient were followed by a delayed slow inward current. This resulted from rnuscarinic receptor stimulation since it was greatly attenuated or blocked by 1 ~.M atropine, without any decrement in the initial Ca 2+ transient. The ACh-induced secondary inward current was also blocked by calphostin C without significant change in the primary (nicotinic) Ca 2+ influx (see Figure 6 ), indicating that it resulted from PKC activation.
ACh Activates the Slow CI Current by a Synergistic Action on Muscarinic and Nicotinic Receptors
Discussion
In these experiments, we have detected a CI-current that appears to require both a rise in [Ca2÷]~ and activation of PKC for its generation. Thus, under normal circumstances, a pulsatile rise of >400-600 nM [Ca~÷]~ suffices to trigger the current. This threshold is lowered if PKC is simultaneously activated (either with an exogenous activator or by stimulating PLC-linked receptors), though not to resting levels, since we never detected the current in the absence of a priming Ca 2+ charge even after strong PKC activation. Conversely, the threshold was raised to in excess of 1-2 ~M when PKC was inactivated by calphostin C or down-regulated by phorbol ester pretreatment. Indeed, under these conditions, we were very rarely able to detect the current following the largest Ca 2÷ rises we could achieve. This implies that not only may there be an absolute requirement of PKC-mediated phosphorylation for expression of the current but also that a Ca2+-dependent isozyme of PKC is most probably involved. A possible candidate is PKCI~, since this has been identified immunohistochemically in these cells (Roivainen et al., 1991) .
There was a substantial delay of several seconds between the rise in Ca 2÷ and the development of the current. For this reason, we think it unlikely that the channels responsible for the current are directly activated by Ca 2÷. Although rat sympathetic neurons do possess a true Ca 2+-activated CI-current (Sanchez-Vives and Gallego, 1994), this is activated extremely rapidly during the initial Ca 2+ transient, appearing as an inward current tail immediately following the voltage-gated Ca 2+ current (see, e.g., Figure  3A ; see also Figure 5 in Trouslard et al., 1993) . Moreover, unlike the delayed current, it was not augmented by PKC activation or reduced by pretreatment with calphostin C.
Instead, we suggest that the interaction between Ca 2÷ and DAGs is at the level of the PKC enzyme and that the role of the priming Ca 2÷ rise is to induce the membrane binding of the enzyme where it can then be activated by membrane-associated phospholipids and DAG (see Wolf et al., 1985; McArdle et al., 1986; TerBush et al., 1988; Huang, 1989) . In this case, the delay in current onset represents the time taken for membrane binding and effective "translocation" of PKC. One argument in favor of this as the rate-limiting step is that the PKC activators, though augmenting the current amplitude, did not shorten the delay. Likewise, a similar delay occurred irrespective of whether PKC was activated throughout the recording or in a punctate manner by (for instance) pressure application of ACh. Finally, we have noted that a similar delay occurred in the incremental current produced by a second charge of Ca 2+ (induced by a second voltage step) applied at the peak of the first delayed current. Hence, we further speculate that the current is generated not by Ca 2+ itself, but through channel opening consequent upon PKCmediated phosphorylation. In this case, recovery of the current would depend upon the rates of DAG metabolism, PKC deactivation, and subsequent dephosphorylation processes. The prolongation of the current following application of PDBu would then be expected as a consequence of its lack of metabolism and persistent PKC activation. Thus, assuming our interpretation to be correct, one useful consequence of our observations is that the time course of this response could potentially provide information about the rates of functional PKC activation and deactivation in mammalian neurons.
Since we have not yet succeeded in recording the activity of the underlying channels and therefore cannot study the channels in isolated membranes, we are unable to say whether PKC phosphorylates the channels themselves or some other upstream protein, but the former is at least plausible. An analogy for this line of thinking would be the cystic fibrosis transmembrane conductance regulator channels (Welsh et al., 1992) , though the channels responsible for the ganglion cell current are clearly not cystic fibrosis transmembrane conductance regulator channels since the ganglion cell current was not augmented by stimulating PKA. A variety of PKC-activated CI-channels have been described in nonneuronal cell types (e.g., Walsh, 1991; Robson and Hunter, 1994; Schumann and Raffin 1994) , but, in the absence of single-channel information, further speculation about the nature of the ganglion cell channels seems premature.
Of more interest from the viewpoint of neuronal function is the fact that the current can be activated by a brief application of the natural transmitter ACh. This arises because ACh induces both of the synergizing trigger events: activation of Ca 2+ permeable nicotinic receptors induces the priming rise of Ca 2+ that we postulate to be required for PKC translocation and membrane binding, and stimulation of muscarinic receptors induces the rise in membrane-associated DAG leading to PKC activation. This is an important observation because it means that the PKC does not have to be preactivated to generate the CI-current: there is sufficient time for the sequence of coactivation by Ca 2÷ and DAG, translocation, and (presumed) phosphorylation when the nicotinic and muscarinic receptors are briefly activated simultaneously, as they would be during synaptic transmission. The failure of muscarinic agonists to change the [Ca2+]i levels significantly is a consistent observation in these cells (e.g., Wanke et al., 1987; Beech et al., 1991) . We cannot, as yet, supply a feasible explanation for this apparent anomaly, particularly since muscarinic receptor activation does increase inositolphosphate turnover (see Introduction). However, it does appear that, under our experimental conditions at least, Ca 2+ entry through voltage-gated Ca 2÷ channels and ligand-gated cation channels has a much stonger influence on averaged [Ca2+]~ than does agonist-induced release from IP3-sensitive stores.
In conclusion, in these experiments, we have detected an interesting synergistic response to Ca 2+ entry through Ca 2÷ permeable channels and DAG production mediated through the action of a single transmitter on two different receptors, one ligand gated and one PLC linked. Since this combination of receptors is not unique to ACh but extends to some other transmitters such as glutamate, 5-hydroxytryptamine, and ATP, such a synergistic interac-tion may be quite a widespread phenomenon in the vertebrate nervous system.
Experimental Procedures
Cell Preparation Superior cervical ganglia of young (17 days postnatal) rats were removed and dissociated according to the methods of Marrion et al. (1987) . The cells were maintained in culture for a period of 1-3 days within a humidified incubator (5o/0:95o/0 CO2:O2) at 37°C before use. The elevated K + L15 culture medium contained an additional 45 mM KCI.
Recording Methods
The combined single-cell electrophysiological/microfluorimetric methods used in the present study are essentially those applied in our previous papers (Trouslard et al., 1993; Robbins et al., 1992) , i.e., the whole-cell variant of the patch clamp (Hamill et al., 1981) using an EPC-7 voltage clamp amplifier (List) with simultaneous estimation of [Ca2+]~ using the fluorescent Ca 2÷ probe Indo-1 (Grynkiewicz et al., 1985) . We have additionally utilized the perforated patch method (Horn and Marty, 1987; Rae et al., 1991) , which has not only allowed us to maintain the cell internal milieu but also prolonged the single-cell microfluorimetric measurements of [Ca2+]~. For the perforated patch experiments, cells were preloaded with the acetoxymethyl ester (AM) form of Indo-1 by incubation with 0.5 pM Indo-1 AM for 30 min in the culture medium at 37°C. They were then superfused with the external solution for 20-30 min to allow ester hydrolysis. To check for interference by possible toxic breakdown products of Indo-1 AM, in five experiments, cells were loaded with Indo-1 AM at 22°C; the results with muscarinic agonists were indistinguishable from those observed on loading at 37°C.
Indo-1 was excited at 360 nm, and the intensity of emitted light at 407 and 488 nm was recorded using photomultiplier tubes. A homemade amplifier allowed us to subtract cell autofluoresence and background light and then ratio the two photomultiplier signals. The proportionate output of the amplifier (1 V per ratio) was then digitized and acquired on a computer (Dell 486•66) together with the whole-cell current and command potentials outputs from the EPC-7 amplifier using a Labmaster (TL-1) interface. The Labmaster computer interface board was driven either by in-house software (Calgrab 2.0) that both acquired and displayed [Ca2+]i on line at 100 Hz or by Clampex (Axon Instruments) to control the ramp protocol used in reversal potential determinations. A full account of our experimental apparatus, the calculation of [Ca2÷]~, and the calibration procedure has been previously described (Trouslard et al., 1993) .
Perforated Patch Method
Stock solutions of nystatin (50 mg/ml) or amphotericin B (100 mg/ml) in dimethyl sulfoxide (DMSO) were ultrasonicated (2 rain at 20°C). These stock solutions were made up daily and kept refrigerated until used. Nystatin (0.25 mg/ml) and amphotericin B (0.125 mg/ml) were dissolved and ultrasonicated in the intracellular solution just before use. To aid the formation of a gigaseal, tips of the recording electrodes were dipped into standard intracellular solution for 10-60 s and then back-filled with permeabilizing intracellular solution. A gigaseal normally formed within 30 s, while a low resistance path into the cell was typically obtained within 10 rain. Cells were left in this configuration to dialyse for 20-30 min before begining the experiment. We normally obtained final series resistances of 15-35 M~ for nystatin and 8-15 M'~ for amphotericin B.
Solutions
The standard external solution consisted of 118 mM NaCI, 6 mM KCI, 1.5 mM MgCI2, 2.5 mM CaCI2, 10 mM glucose, and 10-20 mM HEPES, buffered to pH 7.2 using NaOH; this solution was oxygenated throughout the experiment using 100% O2. Ca~--free solution contained no CaCI2 plus an additional 3.5 mM MgCI2 and 100-500 pM EGTA. Drugs were applied by bath perfusion (10-12 ml per minute), by pressure ejection or by iontophoretic application. When changing the ionic composition of the external solution, the junction potentials were measured using a saturated KCI reference electrode. Reversal potentials were then corrected for any change in junction potentials. All electrophysiological experiments were conducted at 32°C unless otherwise stated.
The internal Cs solution consisted of 90 mM Cs acetate, 50 mM CsCI, 1.5 mM MgCI2, and 10 mM HEPES adjusted to pH 7.2 using NaOH or Tris. When a W-containing internal solution was required, K gluconate isotonically replaced Cs acetate. High internal CI-was achieved by equimolar replacement of Cs acetate with CsCI. For conventional whole-cell recordings, Mg2+-ATP (2 raM) and Indo-1 (100 ~M) were added to the internal solutions.
Drugs and Chemicals
Indo-1, Indo-1 AM, tetrodotoxin, bradykinin, and NPPB were obtained from Calbiochem. Niflumic acid was from Aldrich. Nystatin, amphotericin B, PDBu, 4ot-PDD, staurosporine, DOG, OAG, pirenzepine, and calphostin C were obtained from Sigma. Forskolin and muscarine were obtained from Research Biochemicals Incorporated. DOG, OAG, PDBu, and 4(~-PDD were dissolved in ethanol and stored under nitrogen at -70°C until used. Himbacine was a gift from W. C. Taylor (University of Sydney). Calphostin C (1 mM stock solution), niflumic acid (100 mM), and NPPB (100 mM) were dissolved in DMSO. Inhibition of PKC by calphostin C (100 nM) was achieved by a 1 hr preincubation under laboratory lighting at 22°C-24°C (Bruns et al., 1991) in the presence of 300 pM c{-tocopherol (Wang et al., 1993) . The control cells for the calphostin C experiments were incubated in (~-tocopherolcontaining medium for 1 hr. The cells were then washed in the standard external solution for 30 min before commencing the electrophysiological recordings.
